August 11, 2022
Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations
Media
August 11, 2022
Oncopeptides publishes Q2 report 2022
August 11, 2022
Targovax ASA: Invitation to Targovax’s second quarter and first half 2022 presentation, Thursday 18 August
August 10, 2022
Aro Biotherapeutics Receives FDA Orphan Drug Designation for ABX1100 for the Treatment of Pompe Disease
August 10, 2022
Spruce Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 09, 2022
Fusion Pharmaceuticals Announces Second Quarter 2022 Financial Results And Clinical Program Updates
August 03, 2022
Pulmonx Reports Second Quarter 2022 Financial Results
July 27, 2022
InCarda Therapeutics Announces Enrollment of First Patient in Pivotal Phase 3 RESTORE-1 Trial of InRhythm™ for the Treatment of Paroxysmal Atrial Fibrillation
July 26, 2022
Precirix and Eckert & Ziegler sign agreement on priority supply of the therapeutic radioisotope Actinium-225
July 26, 2022
Q2 2022 General Market Overview
